MARSHALL WACE, LLP - CALLIDITAS THERAPEUTICS AB ownership

CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 18 filers reported holding CALLIDITAS THERAPEUTICS AB in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CALLIDITAS THERAPEUTICS AB
ValueSharesWeighting
Q1 2022$518,000
-74.1%
27,910
-65.4%
0.00%
-75.0%
Q4 2021$1,997,000
+816.1%
80,673
+922.9%
0.00%
+300.0%
Q1 2021$218,0007,8870.00%
Other shareholders
CALLIDITAS THERAPEUTICS AB shareholders Q1 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 200,000$6,724,0002.33%
BVF INC/IL 750,000$25,493,0001.00%
Logos Global Management LP 300,000$10,086,0000.86%
Vivo Capital, LLC 311,030$10,457,0000.47%
HHLR ADVISORS, LTD. 1,047,687$35,611,0000.28%
Pentwater Capital Management LP 50,000$1,681,0000.02%
Point72 Asset Management, L.P. 102,748$3,454,0000.02%
DEUTSCHE BANK AG\ 70,236$2,361,0000.00%
MILLENNIUM MANAGEMENT LLC 20,484$696,0000.00%
JANE STREET GROUP, LLC 7,557$256,0000.00%
View complete list of CALLIDITAS THERAPEUTICS AB shareholders